Chronic Kidney Disease - Pearland TX

Summary:

You are invited to take part in this research study as your kidney function is decreasing over time (chronic kidney disease, CKD). We are doing this study to learn more about the effects of an experimental drug (zibotentan combined with dapagliflozin) on preserving kidney function when taken by participants with CKD, and also to understand better the studied disease and associated health problems. 

Qualified Participants Must:

• At the minmumum be diagnosed with Chronic Kidney Disease

Qualified Participants May Receive:

You will be paid for the visits you complete according to the following schedule: 

$200.00 for first visit, $100.00 for each additional visit, and $50.00 for each phone call visit. 

If you do not complete the study, for any reason, you will be paid for each study visit you do complete. 

You will be paid following each completed visit.